Development of 13H-benzo[f]chromeno[4,3-b][1,7]naphthyridines and their salts as potent cytotoxic agents and topoisomerase I/II alpha inhibitors
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Arepalli, Sateesh Kumar | - |
dc.contributor.author | Lee, Chaerim | - |
dc.contributor.author | Sim, Seongrak | - |
dc.contributor.author | Lee, Kiho | - |
dc.contributor.author | Jo, Hyunji | - |
dc.contributor.author | Jun, Kyu-Yeon | - |
dc.contributor.author | Kwon, Youngjoo | - |
dc.contributor.author | Kang, Jong-Soon | - |
dc.contributor.author | Jung, Jae-Kyung | - |
dc.contributor.author | Lee, Heesoon | - |
dc.date.accessioned | 2021-09-02T05:19:12Z | - |
dc.date.available | 2021-09-02T05:19:12Z | - |
dc.date.created | 2021-06-19 | - |
dc.date.issued | 2018-10-01 | - |
dc.identifier.issn | 0968-0896 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/72534 | - |
dc.description.abstract | A novel series of 35 angularly fused pentacyclic 13H-benzo[f]chromeno[4,3-b][1,7]naphthyridines and 13H-benzo[f]chromeno[4,3-b][1,7]naphthyridin-5-ium chlorides were designed and synthesized. Their cytotoxic activities were investigated against six human cancer cell lines (NCIH23, HCT15, NUGC-3, ACHN, PC-3, and MDA-MB-231). Among all screened compounds; 28, 30, 34, 35, 46, 48, 52, and 53 compounds exhibited potent cytotoxic activities against all tested human cancer cell lines. Further, these potent lead cytotoxic agents were evaluated against human Topoisomerase I and II alpha inhibition. Among them, the compound 48 exhibited dual Topoisomerase I and II alpha inhibition especially at 20 mu M concentrations the compound 48 exhibited 1.25 times more potent Topoisomerase II alpha inhibitory activity (38.3%) than the reference drug etoposide (30.6%). The compound 52 also exhibited excellent (88.4%) topoisomerase I inhibition than the reference drug camptothecin (66.7%) at 100 mu M concentrations. Molecular docking studies of the compounds 48 and 52 with topo I discovered that they both intercalated into the DNA single-strand cleavage site where the compound 48 have van der Waals interactions with residues Arg364, Pro431, and Asn722 whilst the compound 52 have with Arg364, Thr718, and Asn722 residues. Both the compounds 48 and 52 have pi-pi stacking interactions with the stacked DNA bases. The docking studies of the compound 48 with topo IIa explored that it was bound to the topo II alpha DNA cleavage site where etoposide was situated. The benzo[f]chromeno[4,3-b][1,7]naphthyridine ring of the compound 48 was stacked between the DNA bases of the cleavage site with pi-pi stacking interactions and there were no hydrogen bond interactions with topo II alpha. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | PERGAMON-ELSEVIER SCIENCE LTD | - |
dc.subject | NF-KAPPA-B | - |
dc.subject | TERNARY CLEAVABLE COMPLEX | - |
dc.subject | DNA TOPOISOMERASES | - |
dc.subject | BIOLOGICAL EVALUATION | - |
dc.subject | ANTICANCER AGENTS | - |
dc.subject | QUINOLINE DERIVATIVES | - |
dc.subject | CATALYTIC INHIBITORS | - |
dc.subject | II INHIBITORS | - |
dc.subject | DESIGN | - |
dc.subject | CANCER | - |
dc.title | Development of 13H-benzo[f]chromeno[4,3-b][1,7]naphthyridines and their salts as potent cytotoxic agents and topoisomerase I/II alpha inhibitors | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Lee, Kiho | - |
dc.identifier.doi | 10.1016/j.bmc.2018.09.019 | - |
dc.identifier.scopusid | 2-s2.0-85053850083 | - |
dc.identifier.wosid | 000446669400021 | - |
dc.identifier.bibliographicCitation | BIOORGANIC & MEDICINAL CHEMISTRY, v.26, no.18, pp.5181 - 5193 | - |
dc.relation.isPartOf | BIOORGANIC & MEDICINAL CHEMISTRY | - |
dc.citation.title | BIOORGANIC & MEDICINAL CHEMISTRY | - |
dc.citation.volume | 26 | - |
dc.citation.number | 18 | - |
dc.citation.startPage | 5181 | - |
dc.citation.endPage | 5193 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Biochemistry & Molecular Biology | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalResearchArea | Chemistry | - |
dc.relation.journalWebOfScienceCategory | Biochemistry & Molecular Biology | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Medicinal | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Organic | - |
dc.subject.keywordPlus | NF-KAPPA-B | - |
dc.subject.keywordPlus | TERNARY CLEAVABLE COMPLEX | - |
dc.subject.keywordPlus | DNA TOPOISOMERASES | - |
dc.subject.keywordPlus | BIOLOGICAL EVALUATION | - |
dc.subject.keywordPlus | ANTICANCER AGENTS | - |
dc.subject.keywordPlus | QUINOLINE DERIVATIVES | - |
dc.subject.keywordPlus | CATALYTIC INHIBITORS | - |
dc.subject.keywordPlus | II INHIBITORS | - |
dc.subject.keywordPlus | DESIGN | - |
dc.subject.keywordPlus | CANCER | - |
dc.subject.keywordAuthor | 13H-Benzo[f]chromeno[4,3-b][1,7]naphthyridines | - |
dc.subject.keywordAuthor | Dual human Topoisomerase I and II alpha inhibition | - |
dc.subject.keywordAuthor | Cytotoxicity | - |
dc.subject.keywordAuthor | Molecular docking | - |
dc.subject.keywordAuthor | Imino Diels-Alder reaction | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.